Integration planning teams from Merck and Schering-Plough are working together to ensure that the combined company will be well equipped to begin its first day of business as soon as the merger is completed. Merck and Schering-Plough continue to expect the transaction to close in the fourth quarter of 2009.
Richard Clark, chairman, president and CEO of Merck, said: "Approval from the European Commission marks a key milestone for the completion of our transaction with Schering-Plough. We're making good progress towards our closing and look forward to creating a strong, global leader that will make a substantial difference to patients and healthcare around the world."
http://www.datamonitor.com
Republication or redistribution, including by framing or similar means, is expressly prohibited without prior written consent. Datamonitor shall not be liable for errors or delays in the content, or for any actions taken in reliance thereon

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index